nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—Thalidomide—TNF—narcolepsy	0.0784	1	CrCbGaD
Menadione—VKORC1L1—midbrain—narcolepsy	0.0701	0.0883	CbGeAlD
Menadione—F7—brain—narcolepsy	0.0468	0.0589	CbGeAlD
Menadione—F9—brain—narcolepsy	0.0447	0.0563	CbGeAlD
Menadione—PROS1—medulla oblongata—narcolepsy	0.0441	0.0555	CbGeAlD
Menadione—VKORC1L1—brain—narcolepsy	0.0441	0.0555	CbGeAlD
Menadione—NQO2—brainstem—narcolepsy	0.0422	0.0532	CbGeAlD
Menadione—MTHFR—forebrain—narcolepsy	0.0409	0.0515	CbGeAlD
Menadione—PROS1—midbrain—narcolepsy	0.0403	0.0507	CbGeAlD
Menadione—NQO1—forebrain—narcolepsy	0.0341	0.043	CbGeAlD
Menadione—NQO2—medulla oblongata—narcolepsy	0.0294	0.0371	CbGeAlD
Menadione—NQO2—midbrain—narcolepsy	0.0269	0.0339	CbGeAlD
Menadione—GGCX—brain—narcolepsy	0.0266	0.0336	CbGeAlD
Menadione—PROS1—brain—narcolepsy	0.0253	0.0319	CbGeAlD
Menadione—MAOB—brainstem—narcolepsy	0.025	0.0315	CbGeAlD
Menadione—NQO1—medulla oblongata—narcolepsy	0.0246	0.031	CbGeAlD
Menadione—MAOB—forebrain—narcolepsy	0.0241	0.0304	CbGeAlD
Menadione—VKORC1—brain—narcolepsy	0.0228	0.0288	CbGeAlD
Menadione—NQO1—midbrain—narcolepsy	0.0225	0.0284	CbGeAlD
Menadione—MAOB—medulla oblongata—narcolepsy	0.0174	0.0219	CbGeAlD
Menadione—MTHFR—brain—narcolepsy	0.017	0.0214	CbGeAlD
Menadione—F2—brain—narcolepsy	0.017	0.0214	CbGeAlD
Menadione—NQO2—brain—narcolepsy	0.0169	0.0213	CbGeAlD
Menadione—MAOB—midbrain—narcolepsy	0.0159	0.0201	CbGeAlD
Menadione—NQO1—brain—narcolepsy	0.0142	0.0178	CbGeAlD
Menadione—CYP2A6—brain—narcolepsy	0.0136	0.0171	CbGeAlD
Menadione—AOX1—brain—narcolepsy	0.013	0.0164	CbGeAlD
Menadione—CYP2E1—medulla oblongata—narcolepsy	0.0112	0.0141	CbGeAlD
Menadione—MAOB—brain—narcolepsy	0.01	0.0126	CbGeAlD
Menadione—CYP1A1—brain—narcolepsy	0.00703	0.00885	CbGeAlD
Menadione—F7—Circadian rythm related genes—HCRTR1—narcolepsy	0.00699	0.0548	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—HCRTR2—narcolepsy	0.00699	0.0548	CbGpPWpGaD
Menadione—CYP2E1—brain—narcolepsy	0.00641	0.00807	CbGeAlD
Menadione—F2—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.00633	0.0496	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—NPS—narcolepsy	0.00316	0.0248	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00258	0.0202	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00258	0.0202	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00255	0.0199	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00255	0.0199	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—P2RY11—narcolepsy	0.00249	0.0195	CbGpPWpGaD
Menadione—F7—Vitamin B12 Metabolism—TNF—narcolepsy	0.00245	0.0192	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00231	0.0181	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00231	0.0181	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00223	0.0174	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—HCRT—narcolepsy	0.00212	0.0166	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00209	0.0164	CbGpPWpGaD
Menadione—F7—Folate Metabolism—TNF—narcolepsy	0.00199	0.0156	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00189	0.0148	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—PENK—narcolepsy	0.00186	0.0146	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00171	0.0134	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00171	0.0134	CbGpPWpGaD
Menadione—PROS1—Immune System—SOCS2—narcolepsy	0.00166	0.013	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00165	0.0129	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—TRH—narcolepsy	0.0016	0.0126	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—TRH—narcolepsy	0.00158	0.0124	CbGpPWpGaD
Menadione—F7—Selenium Micronutrient Network—TNF—narcolepsy	0.00158	0.0124	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00143	0.0112	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0014	0.011	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00136	0.0107	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00136	0.0107	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HCRTR2—narcolepsy	0.0013	0.0102	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HCRTR1—narcolepsy	0.0013	0.0102	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—P2RY11—narcolepsy	0.00126	0.00984	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00125	0.00979	CbGpPWpGaD
Menadione—MTHFR—Vitamin B12 Metabolism—TNF—narcolepsy	0.00124	0.00971	CbGpPWpGaD
Menadione—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.00122	0.00953	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—TAC1—narcolepsy	0.00117	0.00913	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—NPS—narcolepsy	0.00117	0.00913	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—NPS—narcolepsy	0.00115	0.00902	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00115	0.00902	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HCRT—narcolepsy	0.00107	0.00837	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00106	0.00833	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00104	0.00817	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00104	0.00817	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TNF—narcolepsy	0.00101	0.0079	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—PENK—narcolepsy	0.000951	0.00746	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000932	0.0073	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.000893	0.007	CbGpPWpGaD
Menadione—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.000866	0.00679	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—TNF—narcolepsy	0.000853	0.00668	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—TRH—narcolepsy	0.000809	0.00634	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—TNF—narcolepsy	0.000801	0.00628	CbGpPWpGaD
Menadione—NQO1—Metabolism—CHKB—narcolepsy	0.000788	0.00617	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CHKB—narcolepsy	0.000778	0.0061	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000772	0.00605	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000772	0.00605	CbGpPWpGaD
Menadione—AOX1—Metabolism—CHKB—narcolepsy	0.00076	0.00595	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000735	0.00576	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000735	0.00576	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—TNF—narcolepsy	0.000727	0.0057	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—P2RY11—narcolepsy	0.00071	0.00556	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HRH3—narcolepsy	0.000709	0.00556	CbGpPWpGaD
Menadione—XDH—Metabolism—CHKB—narcolepsy	0.000706	0.00554	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—HTR2A—narcolepsy	0.000701	0.00549	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TNF—narcolepsy	0.000694	0.00544	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HCRTR2—narcolepsy	0.000667	0.00523	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HCRTR1—narcolepsy	0.000667	0.00523	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—P2RY11—narcolepsy	0.000644	0.00505	CbGpPWpGaD
Menadione—MAOB—Metabolism—CHKB—narcolepsy	0.000642	0.00503	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000627	0.00491	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HCRT—narcolepsy	0.000603	0.00473	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—TAC1—narcolepsy	0.000588	0.00461	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—NPS—narcolepsy	0.000588	0.00461	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—TNF—narcolepsy	0.000551	0.00432	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HCRT—narcolepsy	0.000548	0.00429	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PENK—narcolepsy	0.000538	0.00421	CbGpPWpGaD
Menadione—NQO1—Metabolism—CPT1B—narcolepsy	0.000535	0.0042	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CPT1B—narcolepsy	0.000529	0.00414	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000523	0.0041	CbGpPWpGaD
Menadione—AOX1—Metabolism—CPT1B—narcolepsy	0.000516	0.00405	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PENK—narcolepsy	0.000488	0.00383	CbGpPWpGaD
Menadione—XDH—Metabolism—CPT1B—narcolepsy	0.00048	0.00376	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000464	0.00364	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—TRH—narcolepsy	0.000457	0.00358	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DQA1—narcolepsy	0.000452	0.00354	CbGpPWpGaD
Menadione—MAOB—Metabolism—CPT1B—narcolepsy	0.000436	0.00342	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DQB1—narcolepsy	0.000423	0.00331	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—TRH—narcolepsy	0.000415	0.00325	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000403	0.00316	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000403	0.00316	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HRH3—narcolepsy	0.000401	0.00314	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HCRTR1—narcolepsy	0.000394	0.00309	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HCRTR2—narcolepsy	0.000394	0.00309	CbGpPWpGaD
Menadione—F2—Signaling Pathways—P2RY11—narcolepsy	0.000381	0.00298	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRH3—narcolepsy	0.000364	0.00285	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000356	0.00279	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HTR2A—narcolepsy	0.000354	0.00277	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000334	0.00261	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—NPS—narcolepsy	0.000332	0.0026	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—TAC1—narcolepsy	0.000332	0.0026	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HCRT—narcolepsy	0.000324	0.00254	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DRB1—narcolepsy	0.000322	0.00252	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CHKB—narcolepsy	0.000313	0.00245	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—TAC1—narcolepsy	0.000302	0.00236	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NPS—narcolepsy	0.000302	0.00236	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PENK—narcolepsy	0.000288	0.00226	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000257	0.00201	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000257	0.00201	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CHKB—narcolepsy	0.000247	0.00194	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TRH—narcolepsy	0.000245	0.00192	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CHKB—narcolepsy	0.000233	0.00183	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000227	0.00178	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRH3—narcolepsy	0.000215	0.00169	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CPT1B—narcolepsy	0.000213	0.00167	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HTR2A—narcolepsy	0.0002	0.00157	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HTR2A—narcolepsy	0.000181	0.00142	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TAC1—narcolepsy	0.000178	0.0014	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NPS—narcolepsy	0.000178	0.0014	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CPT1B—narcolepsy	0.000168	0.00132	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CPT1B—narcolepsy	0.000158	0.00124	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CHKB—narcolepsy	0.000149	0.00116	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HTR2A—narcolepsy	0.000107	0.00084	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000101	0.000791	CbGpPWpGaD
